Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Abbott Laboratories (NYSE:ABT)

Paying users zone. Data is hidden behind: .

  • Get 1-month access to Abbott Laboratories for $19.99, or

  • get full access to the entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

Cash Flow Statement

Beginner level

The cash flow statement provides information about a company’s cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company’s balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Abbott Laboratories, consolidated cash flow statement

US$ in millions

Microsoft Excel LibreOffice Calc
12 months ended: Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net earnings
Depreciation
Amortization of intangible assets
Share-based compensation
Impact of currency devaluation
Amortization of inventory step-up
Investing and financing (gains) losses, net
Loss on extinguishment of debt
Amortization of bridge financing fees
Gains on sale of businesses
Mylan N.V. equity investment adjustment
Gain on sale of Mylan N.V. shares
Trade receivables
Inventories
Prepaid expenses and other assets
Trade accounts payable and other liabilities
Income taxes
(Increase) decrease in operating capital
Adjustments to reconcile earnings to net cash from operating activities
Net cash from operating activities
Acquisitions of property and equipment
Acquisitions of businesses and technologies, net of cash acquired
Proceeds from business dispositions
Proceeds from the sale of Mylan N.V. shares
Purchases of investment securities
Proceeds from sales of investment securities
Other
Net cash (used in) from investing activities
Proceeds from issuance (repayments) of short-term debt, net and other
Proceeds from issuance of long-term debt and debt with maturities over 3 months
Repayments of long-term debt and debt with maturities over 3 months
Payment of bridge financing fees
Purchase of Alere preferred stock
Acquisition and contingent consideration payments related to business acquisitions
Purchases of common shares
Proceeds from stock options exercised
Dividends paid
Net cash from (used in) financing activities
Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of year
Cash and cash equivalents, end of year

Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19).

Cash flow statement item Description The company
Net cash from operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Abbott Laboratories’s net cash from operating activities increased from 2017 to 2018 but then slightly decreased from 2018 to 2019.
Net cash (used in) from investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Abbott Laboratories’s net cash (used in) from investing activities increased from 2017 to 2018 but then slightly decreased from 2018 to 2019.
Net cash from (used in) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Abbott Laboratories’s net cash from (used in) financing activities decreased from 2017 to 2018 but then increased from 2018 to 2019 exceeding 2017 level.